Your browser doesn't support javascript.
loading
No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes.
Andresen, Kristoffer; Klæboe, Lars Gunnar; Lie, Øyvind Haugen; Broch, Kaspar; Kvaslerud, Anette Borger; Bosse, Gerhard; Hopp, Einar; de Lange, Charlotte; Haugaa, Kristina Hermann; Edvardsen, Thor.
Afiliação
  • Andresen K; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Nydalen, P. O. Box 4950, N-0424, Oslo, Norway.
  • Klæboe LG; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Lie ØH; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Nydalen, P. O. Box 4950, N-0424, Oslo, Norway.
  • Broch K; Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
  • Kvaslerud AB; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Nydalen, P. O. Box 4950, N-0424, Oslo, Norway.
  • Bosse G; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Nydalen, P. O. Box 4950, N-0424, Oslo, Norway.
  • Hopp E; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • de Lange C; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Nydalen, P. O. Box 4950, N-0424, Oslo, Norway.
  • Haugaa KH; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Edvardsen T; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Sci Rep ; 14(1): 6581, 2024 03 19.
Article em En | MEDLINE | ID: mdl-38503845
ABSTRACT
The potential association between endurance exercise and myocardial fibrosis is controversial. Data on exercise exposure and diffuse myocardial fibrosis in endurance athletes are scarce and conflicting. We aimed to investigate the association between exercise exposure and markers of diffuse myocardial fibrosis by cardiovascular magnetic resonance imaging (CMR) in endurance athletes. We examined 27 healthy adult male competitive endurance athletes aged 41 ± 9 years and 16 healthy controls in a cross sectional study using 3 Tesla CMR including late gadolinium enhancement and T1 mapping. Athletes reported detailed exercise history from 12 years of age. Left ventricular total mass, cellular mass and extracellular mass were higher in athletes than controls (86 vs. 58 g/m2, 67 vs. 44 g/m2 and 19 vs. 13 g/m2, all p < 0.01). Extracellular volume (ECV) was lower (21.5% vs. 23.8%, p = 0.03) and native T1 time was shorter (1214 ms vs. 1268 ms, p < 0.01) in the athletes. Increasing exercise dose was independently associated with shorter native T1 time (regression coefficient - 24.1, p < 0.05), but expressed no association with ECV. Our results indicate that diffuse myocardial fibrosis has a low prevalence in healthy male endurance athletes and do not indicate an adverse dose-response relationship between exercise and diffuse myocardial fibrosis in healthy athletes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Meios de Contraste / Cardiomiopatias Limite: Adult / Child / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Meios de Contraste / Cardiomiopatias Limite: Adult / Child / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article